Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
CT
Chia Tai TianQing Pharmaceutical GroupChina - Lianyungang
1 program1
TQC2731 injectionPhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
2029
2030
2031
Chia Tai TianQing Pharmaceutical GroupTQC2731 injection
Airway TherapeuticsBiologic drugs
Clinical Trials (2)
Total enrollment: 3,000 patients across 2 trials
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Start: Sep 2025Est. completion: Sep 2027
Phase 3Recruiting
International Severe CRSwNP Registry 2024-2028
Start: Mar 2025Est. completion: Jan 20323,000 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 3,000 patients
2 companies competing in this space